Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies-Reference-Cited by-同舟云学术

Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies

Published:2007-11 Issue:45 Volume:25 Page:7773-7784
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Stamataki Zania,Coates Stephen,Evans Matthew J.,Wininger Mark,Crawford Kevin,Dong Christine,Fong Yiu-lian,Chien David,Abrignani Sergio,Balfe Peter,Rice Charles M.,McKeating Jane A.,Houghton Michael

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference93 articles.

1. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994;Alter;N Engl J Med,1999

2. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance;Gerlach;Gastroenterology,2003

3. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection;Villano;Hepatology,1999

4. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma;Saito;Proc Natl Acad Sci USA,1990

5. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes;Simmonds;Hepatology,2005

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant H77C gpE1/gpE2 heterodimer elicits superior HCV cross-neutralisation than H77C gpE2 alone;Journal of Hepatology;2024-07

2. Testing a vaccine candidate against Hepatitis C virus designed by combinatorial optimization;Scientific Reports;2023-12-08

3. Microorganisms-derived antigens for preventive anti-cancer vaccines;Molecular Aspects of Medicine;2023-08

4. A pseudovirus-based platform to measure neutralizing antibodies in Mexico using SARS-CoV-2 as proof-of-concept;Scientific Reports;2022-10-26

5. An Equine Model for Vaccination against a Hepacivirus: Insights into Host Responses to E2 Recombinant Protein Vaccination and Subsequent Equine Hepacivirus Inoculation;Viruses;2022-06-27